SOYBEAN OIL

SOYBEAN OIL was reported 680 times

SOYBEAN OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NATURAL KILLER CELL ACTIVITY ABNORMAL 1 0.1667
1 PUNCTURE SITE PRURITUS 1 0.1250
2 FAT OVERLOAD SYNDROME 1 0.1111
3 DEVICE RELATED FUNGAEMIA 1 0.1000
4 RADIATION OEDEMA 1 0.0909
5 AMEGAKARYOCYTIC THROMBOCYTOPENIA 1 0.0588
6 STOMA SITE COMPLICATION 1 0.0556
7 POSTHAEMORRHAGIC HYDROCEPHALUS 3 0.0517
8 VASCULAR ACCESS SITE OCCLUSION 4 0.0506
9 MUCOSAL PROLAPSE SYNDROME 1 0.0370
10 MECONIUM ILEUS 2 0.0303
11 SLEEP DISORDER THERAPY 6 0.0303
12 APPENDICOLITH 10 0.0258
13 PREMATURE BABY DEATH 2 0.0244
14 FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME 1 0.0238
15 SELENIUM DEFICIENCY 1 0.0238
16 PUNCTURE SITE ERYTHEMA 2 0.0233
17 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 1 0.0208
18 PUNCTURE SITE BRUISE 1 0.0196
19 FAT EMBOLISM SYNDROME 1 0.0182
20 CATHETER SITE GRANULOMA 1 0.0175
21 ANTI-MUELLERIAN HORMONE LEVEL DECREASED 1 0.0172
22 CIRCULATORY FAILURE NEONATAL 1 0.0169
23 ADMINISTRATION SITE NODULE 1 0.0167
24 ANTACID THERAPY 2 0.0154
25 BACTEROIDES INFECTION 4 0.0153
26 VENOUS OXYGEN SATURATION DECREASED 1 0.0141
27 ANALGESIC THERAPY 3 0.0093
28 DRUG THERAPY 3 0.0088
29 DISUSE SYNDROME 1 0.0086
30 ROSEOLOVIRUS TEST POSITIVE 1 0.0082
31 CANDIDA ENDOPHTHALMITIS 1 0.0082
32 PSEUDOHYPONATRAEMIA 1 0.0073
33 RETINOPATHY OF PREMATURITY 4 0.0072
34 ANTICOAGULANT THERAPY 2 0.0070
35 TOTAL BILE ACIDS INCREASED 1 0.0068
36 REFEEDING SYNDROME 1 0.0066
37 VASCULAR DEVICE OCCLUSION 2 0.0059
38 BLOOD ZINC DECREASED 1 0.0055
39 CATHETER SITE INDURATION 1 0.0052
40 ABNORMAL CLOTTING FACTOR 1 0.0049
41 PROTEUS TEST POSITIVE 1 0.0045
42 CONGENITAL HIATUS HERNIA 1 0.0044
43 PUNCTURE SITE PAIN 1 0.0043
44 INJECTION SITE PHLEBITIS 1 0.0043
45 GENITAL DISCHARGE 1 0.0042
46 DUODENAL STENOSIS 2 0.0041
47 HYPERPYREXIA 17 0.0040
48 PROCEDURAL INTESTINAL PERFORATION 1 0.0037
49 HYPERPHOSPHATAEMIA 8 0.0037
50 COAGULATION FACTOR DECREASED 1 0.0037
51 LIMBIC ENCEPHALITIS 1 0.0036
52 SUPERFICIAL VEIN THROMBOSIS 3 0.0036
53 PERIVENTRICULAR LEUKOMALACIA 1 0.0035
54 HYPERVISCOSITY SYNDROME 1 0.0035
55 DEVICE COMPUTER ISSUE 1 0.0033
56 DUODENAL OBSTRUCTION 1 0.0033
57 DEVICE RELATED BACTERAEMIA 1 0.0032
58 GASTROENTERITIS RADIATION 1 0.0030
59 BREAST HAEMORRHAGE 1 0.0030
60 BILIRUBIN CONJUGATED INCREASED 7 0.0030
61 BLOOD PHOSPHORUS INCREASED 8 0.0029
62 PNEUMONITIS ASPIRATION 1 0.0029
63 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
64 DERMATITIS DIAPER 2 0.0028
65 CHRONIC RESPIRATORY DISEASE 1 0.0028
66 IMMUNE-MEDIATED CHOLANGITIS 1 0.0028
67 TRANCE 1 0.0027
68 ANISOCORIA 1 0.0026
69 RADIATION OESOPHAGITIS 1 0.0026
70 SKIN ULCER HAEMORRHAGE 1 0.0026
71 BRONCHOPULMONARY DYSPLASIA 2 0.0025
72 INFANTILE APNOEA 2 0.0025
73 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
74 MENINGOENCEPHALITIS HERPETIC 1 0.0022
75 EPIDERMOLYSIS 1 0.0022
76 VASCULAR PAIN 2 0.0021
77 TUMOUR INVASION 1 0.0021
78 DEVICE RELATED SEPSIS 4 0.0020
79 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
80 FOCAL NODULAR HYPERPLASIA 1 0.0019
81 OCCULT BLOOD 1 0.0019
82 INFUSION SITE VESICLES 1 0.0019
83 IRON DEFICIENCY 8 0.0018
84 PHLEBITIS 9 0.0018
85 LARYNGEAL STENOSIS 1 0.0017
86 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
87 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
88 PSOAS ABSCESS 1 0.0016
89 ANION GAP 1 0.0016
90 PERITONEAL DISORDER 1 0.0015
91 ENTEROCOCCUS TEST POSITIVE 1 0.0015
92 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
93 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
94 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
95 BLOOD URIC ACID INCREASED 8 0.0014
96 ESCHAR 1 0.0014
97 BILIARY DILATATION 2 0.0014
98 AMINO ACID LEVEL INCREASED 1 0.0013
99 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
100 STOMA SITE HAEMORRHAGE 2 0.0013
101 METAPNEUMOVIRUS INFECTION 1 0.0013
102 TOTAL LUNG CAPACITY DECREASED 2 0.0013
103 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
104 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
105 ANAL ULCER 1 0.0012
106 HYPOPHOSPHATAEMIA 9 0.0012
107 OESOPHAGEAL PERFORATION 1 0.0012
108 INFUSION SITE OEDEMA 1 0.0012
109 HYPERTRIGLYCERIDAEMIA 7 0.0012
110 HEPATIC HAEMORRHAGE 1 0.0012
111 CHILLS 134 0.0011
112 UPPER AIRWAY OBSTRUCTION 1 0.0011
113 ENTEROCOLITIS INFECTIOUS 1 0.0011
114 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
115 APPENDICITIS 10 0.0011
116 TEMPERATURE INTOLERANCE 11 0.0011
117 DEVICE RELATED INFECTION 16 0.0010
118 DEVICE RELATED THROMBOSIS 1 0.0010
119 PYURIA 1 0.0010
120 MESENTERIC VEIN THROMBOSIS 1 0.0010
121 IMMUNE-MEDIATED DERMATITIS 1 0.0010
122 MYASTHENIA GRAVIS 8 0.0010
123 TUMOUR NECROSIS 1 0.0009
124 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
125 AMAUROSIS FUGAX 1 0.0009
126 KLEBSIELLA SEPSIS 1 0.0009
127 VASCULAR DEVICE INFECTION 4 0.0009
128 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
129 BLOOD FIBRINOGEN DECREASED 1 0.0009
130 RECTAL ULCER 1 0.0009
131 HYPERTENSIVE EMERGENCY 1 0.0008
132 ESCHERICHIA TEST POSITIVE 1 0.0008
133 ENCEPHALITIS VIRAL 1 0.0008
134 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
135 MALIGNANT MELANOMA IN SITU 1 0.0008
136 RECTAL TENESMUS 1 0.0008
137 SYSTEMIC CANDIDA 2 0.0008
138 CANCER PAIN 2 0.0008
139 INFUSION SITE IRRITATION 1 0.0008
140 NON-HODGKIN'S LYMPHOMA 1 0.0008
141 LUNG OPACITY 2 0.0008
142 BRASH SYNDROME 1 0.0007
143 CEREBELLAR HAEMORRHAGE 1 0.0007
144 MENINGITIS BACTERIAL 1 0.0007
145 PANCREATIC ENZYMES INCREASED 1 0.0007
146 INFUSION SITE REACTION 2 0.0007
147 TROPONIN INCREASED 5 0.0007
148 PNEUMONIA PSEUDOMONAL 1 0.0007
149 CALCULUS URINARY 1 0.0006
150 PULMONARY HAEMORRHAGE 5 0.0006
151 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
152 VENTRICULAR FIBRILLATION 7 0.0006
153 AORTIC VALVE DISEASE 1 0.0006
154 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
155 ASPHYXIA 5 0.0006
156 SEBORRHOEIC DERMATITIS 1 0.0006
157 CORONAVIRUS INFECTION 4 0.0006
158 HYPERNATRAEMIA 3 0.0006
159 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
160 DYSPHORIA 3 0.0006
161 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
162 SEIZURE LIKE PHENOMENA 1 0.0006
163 REGURGITATION 2 0.0006
164 INJECTION SITE OEDEMA 1 0.0006
165 MILIARIA 1 0.0006
166 BLOOD CHLORIDE INCREASED 1 0.0006
167 AORTIC STENOSIS 2 0.0006
168 PSEUDOMONAL SEPSIS 1 0.0006
169 JUGULAR VEIN THROMBOSIS 1 0.0006
170 LIVER FUNCTION TEST INCREASED 12 0.0006
171 OPPORTUNISTIC INFECTION 1 0.0005
172 GRANULOCYTE COUNT DECREASED 1 0.0005
173 BACTERIAL INFECTION 10 0.0005
174 ENTEROCOLITIS 3 0.0005
175 HEPATIC MASS 1 0.0005
176 TACHYPNOEA 7 0.0005
177 EPIGASTRIC DISCOMFORT 2 0.0005
178 ANORECTAL DISORDER 1 0.0005
179 VITAMIN B12 DEFICIENCY 2 0.0005
180 IMMUNE-MEDIATED HEPATITIS 1 0.0005
181 EXTRAVASATION 2 0.0005
182 ANAPHYLACTOID REACTION 2 0.0005
183 SUBILEUS 1 0.0005
184 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
185 VASCULAR OCCLUSION 1 0.0005
186 SLEEP DEFICIT 1 0.0005
187 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
188 RADIATION PNEUMONITIS 1 0.0005
189 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
190 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
191 LYMPHOCYTOSIS 1 0.0005
192 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
193 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
194 PSEUDOMEMBRANOUS COLITIS 1 0.0004
195 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
196 DISTRIBUTIVE SHOCK 1 0.0004
197 KOUNIS SYNDROME 1 0.0004
198 CHEST DISCOMFORT 45 0.0004
199 ESCHERICHIA BACTERAEMIA 1 0.0004
200 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
201 URINARY HESITATION 1 0.0004
202 CARDIOGENIC SHOCK 6 0.0004
203 PULSE ABNORMAL 1 0.0004
204 LYMPHADENITIS 1 0.0004
205 NEURALGIA 10 0.0004
206 STAPHYLOCOCCAL SEPSIS 2 0.0004
207 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
208 HEPATOSPLENOMEGALY 1 0.0004
209 PHYSICAL DECONDITIONING 1 0.0004
210 MUCORMYCOSIS 1 0.0004
211 PYREXIA 133 0.0004
212 CYANOSIS 6 0.0004
213 BLOOD LACTIC ACID INCREASED 2 0.0004
214 BLOOD SODIUM INCREASED 1 0.0004
215 LIP BLISTER 1 0.0004
216 PLEURITIC PAIN 1 0.0004
217 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
218 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
219 RESPIRATORY SYMPTOM 1 0.0004
220 HYPERTONIC BLADDER 1 0.0003
221 LIVER FUNCTION TEST ABNORMAL 10 0.0003
222 BODY TEMPERATURE INCREASED 7 0.0003
223 GASTROINTESTINAL NECROSIS 1 0.0003
224 ASCITES 10 0.0003
225 PURPURA 3 0.0003
226 THORACIC VERTEBRAL FRACTURE 1 0.0003
227 HYPERLIPIDAEMIA 4 0.0003
228 ATYPICAL PNEUMONIA 1 0.0003
229 OROPHARYNGEAL DISCOMFORT 3 0.0003
230 CENTRAL VENOUS CATHETERISATION 1 0.0003
231 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
232 SWELLING OF EYELID 2 0.0003
233 RESPIRATORY RATE DECREASED 1 0.0003
234 INFUSION SITE SWELLING 2 0.0003
235 HEPATITIS B REACTIVATION 1 0.0003
236 VULVOVAGINAL DRYNESS 1 0.0003
237 RASH GENERALISED 8 0.0003
238 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
239 NEPHRITIS 1 0.0003
240 ABDOMINAL DISTENSION 31 0.0003
241 BLOOD BILIRUBIN INCREASED 8 0.0003
242 HEPATIC FUNCTION ABNORMAL 11 0.0003
243 PALPITATIONS 34 0.0003
244 GRANULOMA 1 0.0003
245 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
246 ERYTHEMA NODOSUM 1 0.0003
247 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
248 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
249 METABOLIC ACIDOSIS 9 0.0003
250 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
251 LIVER TRANSPLANT 1 0.0003
252 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
253 AMYLASE INCREASED 1 0.0003
254 STEVENS-JOHNSON SYNDROME 6 0.0003
255 CARDIAC DYSFUNCTION 1 0.0003
256 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
257 THYROID MASS 1 0.0003
258 APNOEA 2 0.0003
259 TESTIS CANCER 1 0.0003
260 SKIN ODOUR ABNORMAL 1 0.0003
261 PNEUMONIA FUNGAL 1 0.0003
262 ULCER 4 0.0003
263 SKIN PAPILLOMA 1 0.0002
264 SHOCK HAEMORRHAGIC 2 0.0002
265 HYPERURICAEMIA 1 0.0002
266 VENTRICULAR TACHYCARDIA 4 0.0002
267 GASTROINTESTINAL PERFORATION 1 0.0002
268 INFUSION SITE ERYTHEMA 2 0.0002
269 POOR PERIPHERAL CIRCULATION 1 0.0002
270 PURULENT DISCHARGE 1 0.0002
271 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
272 BLOOD CALCIUM INCREASED 2 0.0002
273 GINGIVAL SWELLING 1 0.0002
274 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
275 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
276 RESPIRATORY RATE INCREASED 2 0.0002
277 RHINITIS ALLERGIC 1 0.0002
278 ANAL INCONTINENCE 2 0.0002
279 PALLOR 6 0.0002
280 LUMBAR VERTEBRAL FRACTURE 1 0.0002
281 BLOOD TEST ABNORMAL 3 0.0002
282 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
283 VAGINAL INFECTION 1 0.0002
284 CARDIAC TAMPONADE 1 0.0002
285 GESTATIONAL DIABETES 1 0.0002
286 CHOLESTASIS 4 0.0002
287 HYPERCHOLESTEROLAEMIA 2 0.0002
288 THROMBOTIC MICROANGIOPATHY 2 0.0002
289 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
290 BREATH SOUNDS ABNORMAL 1 0.0002
291 HYPERVOLAEMIA 1 0.0002
292 PNEUMONIA ASPIRATION 5 0.0002
293 HAEMATEMESIS 5 0.0002
294 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
295 ENDOCARDITIS 1 0.0002
296 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
297 TRISMUS 1 0.0002
298 HYPERBILIRUBINAEMIA 2 0.0002
299 THERAPY PARTIAL RESPONDER 3 0.0002
300 PNEUMOTHORAX 3 0.0002
301 NYSTAGMUS 1 0.0002
302 ANAL ABSCESS 1 0.0002
303 ERYTHEMA OF EYELID 1 0.0002
304 HYDROCEPHALUS 1 0.0002
305 CHOKING SENSATION 1 0.0002
306 TRANSAMINASES INCREASED 4 0.0002
307 FEELING COLD 5 0.0002
308 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
309 CARDIAC VALVE DISEASE 1 0.0002
310 GASTRIC HAEMORRHAGE 2 0.0002
311 HERPES VIRUS INFECTION 1 0.0002
312 HYPOKALAEMIA 8 0.0002
313 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
314 RALES 1 0.0002
315 STRESS CARDIOMYOPATHY 1 0.0002
316 LYMPHOCYTE COUNT DECREASED 3 0.0002
317 BACTERAEMIA 2 0.0002
318 GOUT 3 0.0002
319 INFUSION RELATED REACTION 11 0.0002
320 HEPATITIS B 1 0.0002
321 INGUINAL HERNIA 1 0.0002
322 INFUSION SITE EXTRAVASATION 1 0.0002
323 HYPONATRAEMIA 9 0.0002
324 SCREAMING 1 0.0002
325 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
326 PROCTALGIA 1 0.0002
327 HERPES SIMPLEX 1 0.0002
328 SEPSIS 17 0.0002
329 HYPOGAMMAGLOBULINAEMIA 1 0.0002
330 BLOOD CHOLESTEROL INCREASED 7 0.0002
331 IRRITABILITY 9 0.0001
332 SWELLING 14 0.0001
333 CYTOKINE RELEASE SYNDROME 3 0.0001
334 JAUNDICE 4 0.0001
335 BRONCHIECTASIS 1 0.0001
336 POSTOPERATIVE WOUND INFECTION 1 0.0001
337 HYPERHIDROSIS 19 0.0001
338 PRODUCT LABEL ISSUE 1 0.0001
339 CROHN'S DISEASE 1 0.0001
340 ECCHYMOSIS 1 0.0001
341 RESPIRATION ABNORMAL 1 0.0001
342 FORMICATION 1 0.0001
343 HYPOMAGNESAEMIA 2 0.0001
344 DEVICE OCCLUSION 2 0.0001
345 PAPULE 1 0.0001
346 FEAR OF INJECTION 1 0.0001
347 GRAFT VERSUS HOST DISEASE 1 0.0001
348 PANIC REACTION 1 0.0001
349 GASTROENTERITIS 2 0.0001
350 MOUTH HAEMORRHAGE 1 0.0001
351 HEPATOCELLULAR CARCINOMA 1 0.0001
352 HAEMODYNAMIC INSTABILITY 1 0.0001
353 DIABETES MELLITUS 10 0.0001
354 HYPERTHERMIA 1 0.0001
355 ACIDOSIS 1 0.0001
356 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
357 HAEMOLYSIS 1 0.0001
358 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
359 HYPOALBUMINAEMIA 1 0.0001
360 ACUTE MYELOID LEUKAEMIA 2 0.0001
361 FLUSHING 13 0.0001
362 SLEEP DISORDER 9 0.0001
363 TORSADE DE POINTES 1 0.0001
364 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
365 ANAPHYLACTIC REACTION 7 0.0001
366 PULMONARY EMBOLISM 12 0.0001
367 TRICUSPID VALVE INCOMPETENCE 1 0.0001
368 GINGIVAL PAIN 1 0.0001
369 HYPOTHYROIDISM 4 0.0001
370 MUSCLE TIGHTNESS 2 0.0001
371 HICCUPS 1 0.0001
372 CYTOMEGALOVIRUS INFECTION 2 0.0001
373 COAGULOPATHY 2 0.0001
374 LIVE BIRTH 1 0.0001
375 FACE OEDEMA 2 0.0001
376 INADEQUATE ANALGESIA 1 0.0001
377 CIRCULATORY COLLAPSE 2 0.0001
378 ANAPHYLACTIC SHOCK 3 0.0001
379 DELIRIUM 4 0.0001
380 VOMITING 54 0.0001
381 URINE OUTPUT DECREASED 1 0.0001
382 TUMOUR LYSIS SYNDROME 1 0.0001
383 COLD SWEAT 2 0.0001
384 LUNG INFILTRATION 1 0.0001
385 CARDIOTOXICITY 1 0.0001
386 HAEMOLYTIC ANAEMIA 1 0.0001
387 DRY MOUTH 9 0.0001
388 END STAGE RENAL DISEASE 2 0.0001
389 HIDRADENITIS 1 0.0001
390 OVARIAN CANCER 1 0.0001
391 IRON DEFICIENCY ANAEMIA 1 0.0001
392 RENAL DISORDER 5 0.0001
393 ERYTHEMA MULTIFORME 1 0.0001
394 DEFORMITY 1 0.0001
395 SPUTUM DISCOLOURED 1 0.0001
396 NAUSEA 83 0.0001
397 ATELECTASIS 1 0.0001
398 ERUCTATION 2 0.0001
399 DIZZINESS POSTURAL 1 0.0001
400 INTENTIONAL PRODUCT MISUSE 9 0.0001
401 RENAL TUBULAR NECROSIS 1 0.0001
402 VITREOUS FLOATERS 1 0.0001
403 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
404 PRESCRIBED UNDERDOSE 2 0.0001
405 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
406 THROMBOSIS 8 0.0001
407 ABDOMINAL PAIN 23 0.0001
408 TOOTH ABSCESS 1 0.0001
409 NEUTROPHIL COUNT DECREASED 4 0.0001
410 EPILEPSY 3 0.0001
411 NEUTROPHIL COUNT INCREASED 1 0.0001
412 RIB FRACTURE 2 0.0001
413 PERITONITIS 2 0.0001
414 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
415 FULL BLOOD COUNT ABNORMAL 1 0.0001
416 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
417 PLATELET COUNT DECREASED 10 0.0001
418 EPISTAXIS 7 0.0001
419 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
420 ASPIRATION 1 0.0001
421 STAPHYLOCOCCAL INFECTION 3 0.0001
422 MELAENA 2 0.0001
423 FEBRILE NEUTROPENIA 6 0.0001
424 BLOOD PRESSURE DECREASED 6 0.0001
425 LIVER DISORDER 4 0.0001
426 MEDICATION ERROR 5 0.0001
427 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
428 PANCYTOPENIA 5 0.0001
429 ORAL PAIN 2 0.0001
430 ANAEMIA 17 0.0001
431 INTESTINAL PERFORATION 1 0.0001
432 PANCREATITIS ACUTE 2 0.0001
433 OXYGEN SATURATION DECREASED 5 0.0001
434 MITRAL VALVE INCOMPETENCE 1 0.0001
435 MICTURITION URGENCY 1 0.0001
436 ELECTROLYTE IMBALANCE 1 0.0001
437 EYELID OEDEMA 1 0.0001
438 SPLENOMEGALY 1 0.0001
439 COVID-19 PNEUMONIA 1 0.0001
440 RENAL IMPAIRMENT 7 0.0001
441 MENTAL IMPAIRMENT 2 0.0001
442 ADRENAL INSUFFICIENCY 1 0.0001
443 NOCTURIA 1 0.0001
444 HYPERGLYCAEMIA 3 0.0001
445 NO THERAPEUTIC RESPONSE 1 0.0001
446 DISCOMFORT 5 0.0001
447 MUSCLE SPASTICITY 1 0.0001
448 SMALL INTESTINAL OBSTRUCTION 1 0.0001
449 INJECTION SITE EXTRAVASATION 1 0.0001
450 HYPERCALCAEMIA 1 0.0001
451 GENERALISED OEDEMA 1 0.0001
452 HEART RATE INCREASED 8 0.0001
453 ILEUS 1 0.0001
454 SECRETION DISCHARGE 1 0.0001
455 HYPOPHAGIA 2 0.0001
456 MYDRIASIS 1 0.0001
457 DRUG RESISTANCE 2 0.0001
458 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
459 DYSPNOEA 44 0.0001
460 INFUSION SITE PAIN 1 0.0001
461 UNRESPONSIVE TO STIMULI 2 0.0001
462 FREQUENT BOWEL MOVEMENTS 2 0.0001
463 PNEUMONITIS 2 0.0001
464 GINGIVAL BLEEDING 1 0.0001
465 CORONARY ARTERY OCCLUSION 1 0.0001
466 PERIPHERAL COLDNESS 1 0.0001
467 RESPIRATORY DISTRESS 2 0.0001
468 ORAL DISCOMFORT 1 0.0001
469 POLLAKIURIA 3 0.0001
470 HAEMOPTYSIS 2 0.0001
471 MASS 1 0.0001
472 THROMBOCYTOPENIA 8 0.0001
473 SINUS TACHYCARDIA 1 0.0001
474 PRURITUS 27 0.0001
475 PARALYSIS 1 0.0001
476 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
477 TACHYCARDIA 6 0.0001
478 PULMONARY MASS 1 0.0001
479 RESPIRATORY DISORDER 2 0.0001
480 RASH 29 0.0001
481 HYPOAESTHESIA ORAL 1 0.0001
482 HEPATIC FAILURE 2 0.0001
483 INJECTION SITE SWELLING 5 0.0001
484 DRUG ADMINISTRATION ERROR 2 0.0001
485 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
486 DRUG-INDUCED LIVER INJURY 2 0.0001
487 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
488 DRUG INTOLERANCE 6 0.0001
489 INTERSTITIAL LUNG DISEASE 3 0.0001
490 HYPERTENSION 13 0.0001
491 BLOOD CREATININE INCREASED 4 0.0001
492 SEIZURE 7 0.0001
493 DRUG LEVEL INCREASED 1 0.0001
494 URINARY RETENTION 2 0.0001
495 BLOOD UREA INCREASED 1 0.0001
496 CONSTIPATION 13 0.0001
497 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
498 CANDIDA INFECTION 1 0.0001
499 MUSCULOSKELETAL DISCOMFORT 1 0.0001
500 PARANOIA 1 0.0001
501 MULTI-ORGAN FAILURE 1 0.0001
502 SPEECH DISORDER 3 0.0001
503 MUSCULOSKELETAL STIFFNESS 5 0.0001
504 HYPOXIA 2 0.0001
505 DRUG ERUPTION 1 0.0001
506 INJECTION SITE ERYTHEMA 7 0.0001
507 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
508 DIZZINESS 28 0.0001
509 THIRST 1 0.0001
510 CEREBRAL HAEMORRHAGE 2 0.0001
511 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
512 MYELOSUPPRESSION 2 0.0001
513 GASTROENTERITIS VIRAL 1 0.0001
514 OEDEMA 3 0.0001
515 LEUKOCYTOSIS 1 0.0001
516 C-REACTIVE PROTEIN INCREASED 2 0.0001
517 UNDERDOSE 4 0.0001
518 ACCIDENTAL OVERDOSE 2 0.0001
519 SOMNOLENCE 11 0.0001
520 AGITATION 4 0.0001
521 TREMOR 9 0.0001
522 HEPATIC STEATOSIS 1 0.0001
523 ABDOMINAL DISCOMFORT 9 0.0001
524 BLISTER 3 0.0001
525 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
526 PHOTOPHOBIA 1 0.0001
527 HYPOCALCAEMIA 1 0.0001
528 BLOOD URINE PRESENT 1 0.0001
529 PULMONARY FIBROSIS 1 0.0001
530 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
531 ACUTE RESPIRATORY FAILURE 1 0.0001
532 EAR PAIN 1 0.0001
533 OVERDOSE 11 0.0001
534 WHEEZING 3 0.0001
535 HAEMATOCRIT DECREASED 1 0.0001
536 CARDIAC FAILURE 4 0.0000
537 PRODUCT ADMINISTRATION ERROR 1 0.0000
538 STOMATITIS 3 0.0000
539 TASTE DISORDER 1 0.0000
540 DEVICE BREAKAGE 2 0.0000
541 BONE MARROW FAILURE 1 0.0000
542 INJECTION SITE WARMTH 1 0.0000
543 CARDIAC ARREST 4 0.0000
544 DERMATITIS 1 0.0000
545 JOINT INJURY 1 0.0000
546 INTENTIONAL OVERDOSE 3 0.0000
547 PRURITUS GENERALISED 1 0.0000
548 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
549 FAECES DISCOLOURED 1 0.0000
550 CONDITION AGGRAVATED 14 0.0000
551 SEPTIC SHOCK 2 0.0000
552 BLOOD PRESSURE INCREASED 7 0.0000
553 HEPATOTOXICITY 1 0.0000
554 HYPOTENSION 9 0.0000
555 COLITIS ULCERATIVE 2 0.0000
556 RASH PAPULAR 1 0.0000
557 MUSCULAR WEAKNESS 5 0.0000
558 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
559 MUSCLE TWITCHING 1 0.0000
560 PERICARDIAL EFFUSION 1 0.0000
561 INJECTION SITE PAIN 13 0.0000
562 ARRHYTHMIA 2 0.0000
563 RASH ERYTHEMATOUS 2 0.0000
564 HYPOGLYCAEMIA 2 0.0000
565 ATRIAL FIBRILLATION 4 0.0000
566 OEDEMA PERIPHERAL 5 0.0000
567 CEREBRAL INFARCTION 1 0.0000
568 LUNG DISORDER 2 0.0000
569 LIVER INJURY 1 0.0000
570 ENCEPHALOPATHY 1 0.0000
571 PNEUMONIA 13 0.0000
572 HYPOAESTHESIA 6 0.0000
573 AGGRESSION 2 0.0000
574 CELLULITIS 2 0.0000
575 ABDOMINAL PAIN LOWER 1 0.0000
576 CARDIOVASCULAR DISORDER 1 0.0000
577 HEPATITIS 1 0.0000
578 LOSS OF CONSCIOUSNESS 5 0.0000
579 ERYTHEMA 8 0.0000
580 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
581 DEAFNESS 1 0.0000
582 PANCREATITIS 2 0.0000
583 BRADYCARDIA 2 0.0000
584 EAR INFECTION 1 0.0000
585 THROAT TIGHTNESS 1 0.0000
586 HAEMATOCHEZIA 2 0.0000
587 MENTAL STATUS CHANGES 1 0.0000
588 NECK PAIN 2 0.0000
589 INTENTIONAL DOSE OMISSION 1 0.0000
590 RED BLOOD CELL COUNT DECREASED 1 0.0000
591 ANGINA PECTORIS 1 0.0000
592 DECREASED APPETITE 8 0.0000
593 BACK PAIN 8 0.0000
594 URINARY INCONTINENCE 1 0.0000
595 CORONARY ARTERY DISEASE 1 0.0000
596 THERAPEUTIC RESPONSE DECREASED 2 0.0000
597 PLEURAL EFFUSION 2 0.0000
598 FEELING HOT 2 0.0000
599 INJECTION SITE RASH 1 0.0000
600 GYNAECOMASTIA 1 0.0000
601 LIMB DISCOMFORT 1 0.0000
602 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
603 EXPOSURE DURING PREGNANCY 2 0.0000
604 ASTHENIA 12 0.0000
605 CYSTITIS 1 0.0000
606 NIGHT SWEATS 1 0.0000
607 LACTIC ACIDOSIS 1 0.0000
608 CHOLELITHIASIS 1 0.0000
609 DYSPEPSIA 3 0.0000
610 OSTEONECROSIS 1 0.0000
611 LIP SWELLING 1 0.0000
612 FUNGAL INFECTION 1 0.0000
613 SKIN DISORDER 1 0.0000
614 HEPATIC ENZYME INCREASED 2 0.0000
615 INJECTION SITE REACTION 2 0.0000
616 NIGHTMARE 1 0.0000
617 HYPERKALAEMIA 1 0.0000
618 LYMPHADENOPATHY 1 0.0000
619 RESPIRATORY FAILURE 2 0.0000
620 RESTLESSNESS 1 0.0000
621 DYSURIA 1 0.0000
622 CHEST PAIN 5 0.0000
623 DYSGEUSIA 2 0.0000
624 DYSARTHRIA 1 0.0000
625 ASTHMA 3 0.0000
626 COLITIS 1 0.0000
627 ACUTE KIDNEY INJURY 4 0.0000
628 DISEASE PROGRESSION 3 0.0000
629 DISORIENTATION 1 0.0000
630 OFF LABEL USE 22 0.0000
631 ABORTION SPONTANEOUS 1 0.0000
632 DYSKINESIA 1 0.0000
633 RHABDOMYOLYSIS 1 0.0000
634 OSTEOARTHRITIS 1 0.0000
635 MYALGIA 4 0.0000
636 URINARY TRACT INFECTION 4 0.0000
637 MENTAL DISORDER 1 0.0000
638 ANGIOEDEMA 1 0.0000
639 DEHYDRATION 3 0.0000
640 PULMONARY OEDEMA 1 0.0000
641 HEADACHE 14 0.0000
642 GASTROINTESTINAL DISORDER 2 0.0000
643 NEUTROPENIA 3 0.0000
644 SKIN IRRITATION 1 0.0000
645 TINNITUS 1 0.0000
646 ADVERSE EVENT 2 0.0000
647 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
648 HYPERSENSITIVITY 4 0.0000
649 INFECTION 3 0.0000
650 DRY EYE 1 0.0000
651 FLUID RETENTION 1 0.0000
652 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
653 THERAPY CESSATION 1 0.0000
654 PERIPHERAL SWELLING 3 0.0000
655 HAEMORRHAGE 2 0.0000
656 DIARRHOEA 12 0.0000
657 DISTURBANCE IN ATTENTION 1 0.0000
658 RASH PRURITIC 1 0.0000
659 MALAISE 8 0.0000
660 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
661 INFLUENZA 2 0.0000
662 URTICARIA 3 0.0000
663 FLATULENCE 1 0.0000
664 CONVULSION 1 0.0000
665 LETHARGY 1 0.0000
666 BONE PAIN 1 0.0000
667 SURGERY 1 0.0000
668 VISUAL IMPAIRMENT 2 0.0000
669 PRODUCT USE ISSUE 3 0.0000
670 RHINORRHOEA 1 0.0000
671 DEEP VEIN THROMBOSIS 1 0.0000
672 AMNESIA 1 0.0000
673 SWELLING FACE 1 0.0000
674 DRY SKIN 2 0.0000
675 PRODUCT QUALITY ISSUE 2 0.0000
676 PAIN 9 0.0000
677 COUGH 4 0.0000
678 PAIN IN EXTREMITY 4 0.0000
679 BRONCHITIS 1 0.0000
680 HALLUCINATION 1 0.0000
681 HOT FLUSH 1 0.0000
682 DRUG INTERACTION 2 0.0000
683 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
684 CONFUSIONAL STATE 2 0.0000
685 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
686 TOXICITY TO VARIOUS AGENTS 2 0.0000
687 SKIN EXFOLIATION 1 0.0000
688 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
689 COVID-19 2 0.0000
690 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
691 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
692 SUICIDAL IDEATION 1 0.0000
693 NASOPHARYNGITIS 2 0.0000
694 OROPHARYNGEAL PAIN 1 0.0000
695 DYSPHAGIA 1 0.0000
696 NEUROPATHY PERIPHERAL 1 0.0000
697 DEATH 9 0.0000
698 SYNCOPE 1 0.0000
699 SINUSITIS 1 0.0000
700 HAEMOGLOBIN DECREASED 1 0.0000
701 ABDOMINAL PAIN UPPER 2 0.0000
702 DRUG INEFFECTIVE 12 0.0000
703 WEIGHT INCREASED 2 0.0000
704 EMOTIONAL DISTRESS 1 0.0000
705 RENAL FAILURE 1 0.0000
706 ARTHRALGIA 3 0.0000
707 WEIGHT DECREASED 2 0.0000
708 PRODUCT DOSE OMISSION ISSUE 2 0.0000
709 PARAESTHESIA 1 0.0000
710 FALL 2 0.0000
711 NO ADVERSE EVENT 1 0.0000
712 MUSCLE SPASMS 1 0.0000
713 BLOOD GLUCOSE INCREASED 1 0.0000
714 GAIT DISTURBANCE 1 0.0000
715 ALOPECIA 1 0.0000
716 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
717 DEPRESSION 1 0.0000
718 FEELING ABNORMAL 1 0.0000
719 FATIGUE 3 0.0000
720 INSOMNIA 1 0.0000